TITLE

RESULTS FROM A FIVE YEAR COHORT OF PATIENTS UNDERGOING SURVEILLANCE FOR BARRETT'S OESOPHAGUS

AUTHOR(S)
Muddu, A. K.; Fallowfield, J. A.; Davies, N.; Lesna, M.; Winwood, P. J.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA56
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Barrett's oesophagus (BO) is recognised as a premalignant condition for oesophageal adenocorcinoma. The effectiveness of endoscopic surveillance programmes in detecting early stage cancers and in improving outcomes is controversial. Oesophageal cancers detected during surveillance endoscopies were generally diagnosed at an earlier stage than de novo BO associated cancers. Surveillance cancers were resectable and had a better outcome than de novo cancers. The study of authors' supports endoscopic surveillance of selected patients with Barrett's oesophagus.
ACCESSION #
13219031

 

Related Articles

  • Squamous Mucosa Overlying Columnar Epithelium in Barrett's Esophagus in the Absence of Anti-Reflux Surgery. Sampliner, Richard E.; Steinbronn, Karen; Garewal, Harinder S.; Riddell, Robert H. // American Journal of Gastroenterology;May1988, Vol. 83 Issue 5, p510 

    Seven of 45 patients with Barrett's esophagus prospectively followed with yearly endoscopy had histological evidence of squamous mucosa overlying Barrett's epithelium. This histological finding has previously been identified as a rare sequela of anti-reflux surgery. All seven patients had...

  • Benefit of baseline cytometry for surveillance of patients with Barrett’s esophagus. Vogt, Nicole; Schönegg, René; Gschossmann, Jürgen M.; Borovicka, Jan // Surgical Endoscopy;May2010, Vol. 24 Issue 5, p1144 

    The current gold standard for the surveillance of Barrett’s esophagus is the Seattle four-quadrant biopsies protocol (4-QB). Using endoscopic brush cytology, this study prospectively investigated whether digital image cytometry (DICM) is of additional benefit over regular histology as a...

  • SWOG S0356: Combination therapy failed to meet endpoint in esophageal adenocarcinoma.  // Hem/Onc Today;11/25/2011, Vol. 12 Issue 22, p9 

    The article presents a study that examined the pathologic complete response of the SWOG S0356 combination treatment for patients with esophageal adenocarcinoma.

  • CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer. Tomohiko Nishi; Hiroya Takeuchi; Sachiko Matsuda; Masaharu Ogura; Hirofumi Kawakubo; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Yoshiro Saikawa; Tai Omori; Yuko Kitagawa // World Journal of Surgical Oncology;Aug2015, Vol. 13 Issue 1, p1 

    Background: Esophagectomy is one of the most invasive surgical treatments for digestive tract cancer, and the blood levels of inflammatory cytokines such as interleukin-1, interleukin-6, and interleukin-8 are increased for several hours after surgery or in patients experiencing postoperative...

  • Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China. Zheng, Xianzhi; Mao, Xuhua; Xu, Kun; Lü, Lingshuang; Peng, Xianzhen; Wang, Min; Xu, Guisheng; Hua, Zhaolai; Wang, Jianping; Xue, Hengchuan; Wang, Jianming; Lu, Cheng // PLoS ONE;12/23/2015, Vol. 10 Issue 12, p1 

    Objective: This study aims to describe the findings from a massive endoscopic screening program in a high-risk area of China and to evaluate the prognosis of patients diagnosed through endoscopic screening compared with those diagnosed at usual hospital visits because of illness. Methods: In...

  • MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma. Bibby, Becky A. S.; Reynolds, John V.; Maher, Stephen G. // PLoS ONE;7/29/2015, Vol. 10 Issue 7, p1 

    Oesophageal adenocarcinoma (OAC) is the sixth most common cause of cancer deaths worldwide, and the 5-year survival rate for patients diagnosed with the disease is approximately 17%. The standard of care for locally advanced disease is neoadjuvant chemotherapy or, more commonly, combined...

  • Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. Del Genio, A.; Rossetti, G.; Napolitano, V.; Maffettone, V.; Renzi, A.; Brusciano, L.; Russo, G.; Del Genio, G. // Surgical Endoscopy;Dec2004, Vol. 18 Issue 12, p1789 

    Background: Esophageal cancer is associated with a poor tong-term prognosis. Only a 10% 5-year survival rate is reported. This article aims to evaluate the feasibility and efficacy of laparoscopic esophagectomy for the palliative treatment of advanced esophageal cancer (T3-T4 Nx-Nl) after...

  • METHODS OF TREATMENT AND OUTCOMES IN ESOPHAGEAL CANCER SURGERY IN A LOW VOLUME CENTRE. BUȘTEA, CRISTIAN; MAGHIAR, ADRIAN // Acta Medica Transilvanica;mar2014, Vol. 19 Issue 1, p185 

    The incidence of esophageal cancer continues growing, being a global health problem. Nonspecific symptoms occurring late in the disease course result in advanced stages of disease diagnosis. The purpose of this paper is to present the surgical methods of treatment adapted to a general surgery...

  • Optical endomicroscopy and the road to real-time, in vivo pathology: present and future. Carignan, Charles S.; Yukako Yagi // Diagnostic Pathology;2012, Vol. 7 Issue 1, p98 

    Epithelial cancers account for substantial mortality and are an important public health concern. With the need for earlier detection and treatment of these malignancies, the ability to accurately detect precancerous lesions has an increasingly important role in controlling cancer incidence and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics